Not yet recruitingPhase 3NCT07281027
COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"
Studying Epilepsy syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Yale University
- Principal Investigator
- Lawrence Hirsch, MDYale University
- Intervention
- Anakinra(drug)
- Enrollment
- 438 enrolled
- Eligibility
- 2 years · All sexes
- Timeline
- 2026 – 2030
Study locations (30)
- Barrow Institute, Phoenix, Arizona, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- Yale New Haven Hospital, New Haven, Connecticut, United States
- Children's National (DC), Washington D.C., District of Columbia, United States
- University of Florida, Gainesville, Florida, United States
- University of Chicago, Chicago, Illinois, United States
- Northwestern University, Evanston, Illinois, United States
- Mass General (MGH), Boston, Massachusetts, United States
- Beth Israel Deaconess, Boston, Massachusetts, United States
- Boston Children's Hospital, Boston, Massachusetts, United States
- Mayo Clinic, Rochester, Minnesota, United States
- University of Nebraska, Lincoln, Nebraska, United States
- New York University, New York, New York, United States
- Columbia University, New York, New York, United States
- Mount Sinai (NY), New York, New York, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Patient-Centered Outcomes Research Institute
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07281027 on ClinicalTrials.govOther trials for Epilepsy syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT07531745ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet SyndromeIonis Pharmaceuticals, Inc.
- ENROLLING BY INVITATIONNCT07555171EEG Dynamics in Lennox-Gastaut Syndrome Patients Undergoing Fenfluramine TreatmentUniversity of Chicago
- RECRUITINGPHASE3NCT07234695LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down SyndromeFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- RECRUITINGNCT06967727Registry and Natural History of Epilepsy-Dyskinesia SyndromesBoston Children's Hospital
- RECRUITINGNCT07202494Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy AgingAssistance Publique Hopitaux De Marseille
- RECRUITINGNCT05524493High-field MR Imaging in Migraine, Visual Snow and EpilepsyUniversity of Zurich
- RECRUITINGNANCT06847152Spatial Memory and Temporal Lobe EpilepsyCentre Hospitalier Metropole Savoie
- RECRUITINGNANCT06813612Effect of Cognitive Behavioral Play Intervention and EpilepsyIRCCS National Neurological Institute "C. Mondino" Foundation